HC Wainwright & Co. Assumes Autolus Therapeutics at Buy, Announces Price Target of $10

Benzinga · 2d ago
HC Wainwright & Co. analyst Douglas Tsao assumes Autolus Therapeutics (NASDAQ:AUTL) with a Buy rating and announces Price Target of $10.